Dr. Vikram Arya is a Clinical Pharmacology Team Leader in the Division of Infectious Disease Pharmacology (DIDP), Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), FDA. He is primarily responsible for providing technical and strategic leadership on the assessment of clinical pharmacology aspects of antiviral drugs. He is the recipient of the FDA Outstanding Service Award, FDA Leveraging and Collaboration Award, and several CDER Regulatory Science Excellence and Team Excellence Awards to recognize his contributions to review and active participation in a variety of regulatory science and policy setting initiatives. He served as Chair of CDER’s Regulatory Science and Review Enhancement (RSR) Program, is a Fellow of the Excellence in Government (EIG) Fellows Program and is the current Chair of OCP Transporter Scientific Interest Group (SIG). He has presented at various national and international conferences and has numerous publications in peer reviewed journals. He currently serves as the President of the American College of Clinical Pharmacology (ACCP). He holds adjunct faculty appointments at four universities and serves on the Editorial Board of the Journal of Clinical Pharmacology (JCP).